D. C. Miculas, D. M. Ţiț, P. A. Negru, A. G. Tarce, A. F. Bungau
{"title":"\"THE DRUG APPROACHES AND THE ROLE OF HEALTHCARE PROFESSIONALS IN THE MANAGEMENT OF ALZHEIMER’S DISEASE\"","authors":"D. C. Miculas, D. M. Ţiț, P. A. Negru, A. G. Tarce, A. F. Bungau","doi":"10.31688/abmu.2022.57.3.06","DOIUrl":null,"url":null,"abstract":"the same time a symptomatic improvement. The effectiveness of these drugs is clearly limited, both because of several negative side effects and their inefficiency to cure the disease. The therapeutic management is therefore a major challenge in AD, and the non-adherence to treatment often constitutes a serious barrier to an effective therapy. Doctors and pharmacists play a vital role in the pharmacotherapeutic management of AD, contributing to improved clinical results and quality of life of the patient. The current review analysed the challenges in therapeutic management, especially those related to treatment adherence and pharmacist involvement.","PeriodicalId":40057,"journal":{"name":"Archives of the Balkan Medical Union","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-09-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of the Balkan Medical Union","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31688/abmu.2022.57.3.06","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
the same time a symptomatic improvement. The effectiveness of these drugs is clearly limited, both because of several negative side effects and their inefficiency to cure the disease. The therapeutic management is therefore a major challenge in AD, and the non-adherence to treatment often constitutes a serious barrier to an effective therapy. Doctors and pharmacists play a vital role in the pharmacotherapeutic management of AD, contributing to improved clinical results and quality of life of the patient. The current review analysed the challenges in therapeutic management, especially those related to treatment adherence and pharmacist involvement.